COA Certified Ophthalmic Assistant cheat sheet

Visual acuity is recorded as a fraction: the numerator is the test distance (usually 20 ft or 6 m) and the denominator is the distance at which a person with standard vision could read that line; 20/40 means the patient must be at 20 ft to read what standard vision reads at 40 ft.

Snellen chart calibration requires the 20/20 line to sit at the patient's eye level, with the chart illuminated to roughly 10 foot-candles (about 107 lux) and free of glare; test one eye at a time, occluding the fellow eye with a paddle, never with the patient's fingers.

Pinhole testing distinguishes refractive from organic vision loss: improvement through a pinhole indicates uncorrected refractive error, while no improvement suggests media opacity, retinal, or optic nerve disease.

Goldmann applanation tonometry measures intraocular pressure by flattening a fixed 3.06 mm corneal area; each 1 g of force equals 1 mmHg, and fluorescein plus a cobalt-blue filter is needed to view the mires.

Keratometry measures the central corneal curvature over roughly a 3 mm zone; the average corneal power is about 43-44 diopters, and the instrument converts radius of curvature to diopters using the refractive index of the cornea (about 1.376).

Amsler grid testing screens the central 10 degrees of the visual field for metamorphopsia and scotomas; the patient wears reading glasses, fixates on the center dot, and reports distortion or missing areas in each eye separately.

Schiøtz tonometry uses a weighted plunger and a conversion table; it is less accurate after corneal surgery or with irregular astigmatism, and repeated readings must be taken quickly because the instrument displaces aqueous.

Tonometry is affected by central corneal thickness: thick corneas tend to overestimate and thin corneas underestimate true intraocular pressure, so pachymetry readings should accompany Goldmann results.

The tear film has three layers: an outer lipid layer from meibomian glands that retards evaporation, an aqueous middle layer from the lacrimal and accessory glands, and an inner mucin layer from conjunctival goblet cells that anchors tears to the epithelium.

The cornea provides about two-thirds (roughly 60 diopters) of the eye's refractive power, while the crystalline lens contributes about 20 diopters and changes power through accommodation controlled by the ciliary muscle.

Aqueous humor is produced by the ciliary epithelium, flows from the posterior chamber through the pupil into the anterior chamber, and drains mainly through the trabecular meshwork into Schlemm canal and episcleral veins.

Rods mediate scotopic (dim-light) vision, peak in sensitivity near 500 nm, and are absent from the fovea; cones mediate photopic and color vision, with three photopigment types peaking near 420, 534, and 564 nm.

The optic nerve head is the blind spot because it lacks photoreceptors; it sits about 15 degrees nasal to the fovea and corresponds to a physiologic scotoma in each eye's temporal field.

Refractive errors: myopia focuses light anterior to the retina and is corrected with a minus (concave) lens; hyperopia focuses behind the retina and is corrected with a plus (convex) lens; astigmatism is corrected with a cylindrical lens.

The extraocular muscles are four recti (superior, inferior, medial, lateral) and two obliques; the superior oblique is innervated by cranial nerve IV and the lateral rectus by cranial nerve VI, while the rest are supplied by cranial nerve III.

The retinal blood supply is dual: the inner retina is nourished by the central retinal artery, and the outer retina, including photoreceptors, is supplied by the choroidal circulation.

The ocular history follows a structured sequence: chief complaint with onset and duration, ocular history, medical and surgical history, medications, allergies, family history, and social history including smoking and occupational exposures.

Amsler grid, confrontation fields, and pupil testing are screening tests; abnormal results, such as a relative afferent pupillary defect, warrant referral for formal perimetry or neuro-ophthalmic evaluation.

The swinging flashlight test detects a relative afferent pupillary defect: when the light moves from the normal to the affected eye, that pupil dilates instead of constricting, indicating asymmetric optic nerve or retinal disease.

Visual field testing by automated perimetry reports reliability indices: fixation losses, false-positive, and false-negative rates; high error rates reduce confidence in the result and may require retesting.

Optical coherence tomography uses low-coherence interferometry to produce cross-sectional retinal images; it quantifies retinal nerve fiber layer and macular thickness and is central to glaucoma and macular disease monitoring.

Fluorescein angiography requires informed consent and allergy screening; fluorescein is excreted renally and may temporarily discolor urine, and extravasation at the injection site should be managed per office protocol.

Color vision testing with Ishihara plates screens red-green deficiencies; a patient unable to identify any plate may have a severe acquired defect requiring further evaluation rather than simple congenital color blindness.

Refraction documentation uses sphere, cylinder, and axis: the sphere is the spherical power, the cylinder the astigmatic power, and the axis the meridian of the cylinder in degrees from 1 to 180.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.

Ocular emergencies requiring immediate physician notification include chemical burns (irrigate copiously before testing vision), open globe injury (do not apply pressure or measure IOP), and sudden painless vision loss.

Mydriatic and cycloplegic agents: tropicamide is a short-acting mydriatic; cyclopentolate and atropine are cycloplegics with longer duration; phenylephrine is a dilator with minimal cycloplegia and can cause systemic hypertension.

Topical anesthetic abuse causes corneal epithelial toxicity and delayed healing; anesthetics are for procedures only, never for home use, and should not be dispensed to patients.

Infection control requires hand hygiene before and after every patient contact, disinfection of tonometer tips and trial lenses between patients, and proper disposal of sharps in puncture-resistant containers.

Documentation is a legal record: record exactly what was performed and observed, including which eye, times, medications and strengths instilled, and patient statements; never alter a record after the fact except with a dated addendum.

Patients receiving dilating drops should be warned of photophobia and blurred near vision lasting hours, and those with shallow anterior chambers or known angle-closure risk require IOP assessment after dilation per physician direction.

Allergy documentation must be verified before any medication is instilled; record the specific agent and reaction, and flag charts so that dilating or anesthetic agents are not given to a patient with a documented hypersensitivity.

Patient confidentiality is governed by privacy law; discussing patients in public areas, sharing images without consent, or accessing records without a care-related reason violates professional and legal standards.